As of November 14, 2026, Standard Biotools Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on May 28, 2026 (Form 8-K, May 28, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Standard Biotools Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Standard Biotools Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-28. Every row below is cited to the filing it comes from, and this page adds each new change as Standard Biotools Inc. files it.
Layoffs on record: 1 filing or notice, latest 2024-04-25 (layoff filings and notices).
Also on the record for Standard Biotools Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G, by LONG FOCUS CAPITAL MANAGEMENT, LLC | 6% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by MAK CAPITAL ONE LLC | 7.3% of the class | 5%+ stakes | Source |
| July 30, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 2% of the class | 5%+ stakes | Source |
| June 12, 2026 | Stake report, Schedule 13D, by VIKING GLOBAL INVESTORS LP | 15% of the class | 5%+ stakes | Source |
| June 9, 2026 | Stake report, Schedule 13D/A, by Casdin Capital, LLC | 23.9% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by MAK Capital Fund LP | 6.7% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by VIKING GLOBAL INVESTORS LP | 15% of the class | 5%+ stakes | Source |
| January 7, 2026 | Stake report, Schedule 13G, by MAK Capital Fund LP | 5.19% of the class | 5%+ stakes | Source |
| November 28, 2025 | Stake report, Schedule 13D/A, by Casdin Capital, LLC | 24.2% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Standard Biotools Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Standard Biotools Inc. and the records around it.
Standard Biotools Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Casdin Capital, LLC also filed stake reports on 3 other companies: BIOLIFE SOLUTIONS INC (Jun 2026), Relay Therapeutics, Inc. (Feb 2026), Codexis, Inc. (Nov 2025)
- MAK CAPITAL ONE LLC also filed stake reports on 3 other companies: PERMA FIX ENVIRONMENTAL SERVICES INC (Aug 2026), ClearPoint Neuro, Inc. (Aug 2026), HEIDRICK & STRUGGLES INTERNATIONAL INC (Nov 2025)
- MAK Capital Fund LP also filed stake reports on 7 other companies: Comstock Inc. (Oct 2026), Autolus Therapeutics plc (May 2026), ClearPoint Neuro, Inc. (May 2026)
Watch Standard Biotools Inc.
Get an email when Standard Biotools Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Standard Biotools Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Standard Biotools Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Standard Biotools Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-28 | Reported | not named in the filing | 8-K, 2026-05-28 |
New leaders reset buying decisions — get the Full Report on Standard Biotools Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Standard Biotools Inc., with the record behind each one.
Find candidates like senior executive at Standard Biotools Inc.Every change, in the filing's words
Reported
Reasonable outplacement services in accordance with any applicable policy of the Company that is in effect as of the executive's termination (or if no such policy is in effect, as determined by the Company).
- - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 2026 Change of Control and Severance Plan On May 21, 2026, the Board of Directors (the "Board") of Standard BioTools Inc. (the "Company") approved the Company's 2026 Change of Control and Severance Plan and Participation Agreement thereunder (the "2026 Severance Plan").
- The 2026 Severance Plan has a term until August 4, 2028.
- The 2026 Severance Plan is intended to provide certain payments of cash severance and other benefits to the Company's executive leadership team in the event of a qualifying termination of employment with the Company, other than for the Company's Chief Executive Officer who is party to a Participation Agreement under the Company's 2023 Change of Control and Severance Plan (as amended and restated, the "2023 Severance Plan") as further described below.
- Certain members of the Company's executive leadership team, and certain other designated employees are eligible to participate in the 2026 Severance Plan and to receive benefits thereunder.
- For such individuals, the 2026 Severance Plan supersedes the severance and/or change in control related benefits previously provided to such individuals under t he Company's 2024 Change of Control and Severance Plan and any prior employment and severance agreements.
Tools for this story
Each opens in a new tab, filled in for Standard Biotools Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
